Published on

Toxicology – Tramadol


Description

Tramadol is a synthetic analgesic with opioid agonist properties.


Forms and Uses

Tramadol, historically marketed as Ultram, is used for pain relief.

Its analgesic action resembles that of opioid medications, although its direct opioid-receptor activity is weaker than that of many traditional opioids.

A typical adult dose is 50–100 mg, administered by various routes including oral, subcutaneous, intramuscular, rectal, or intravenous routes.


Toxic Dose

The toxic dose of tramadol is not precisely established.

Large ingestions are required for severe poisoning, and ingestion of several grams has been associated with fatal outcomes in adults.


Pathophysiology

Tramadol has several pharmacologic actions.

In addition to opioid activity, it inhibits the reuptake of:

Norepinephrine

and

Serotonin

These actions contribute to its analgesic effects but may also contribute to toxicity.

Severe poisoning may result in:

CNS depression + respiratory depression + hypotension


Epidemiology

Tramadol poisoning is relatively uncommon.


Causes

Exposure may be accidental or intentional.

In very young children, inappropriate exposure may raise concern for neglect or abuse.

In older children, adolescents, and adults, intentional overdose should be considered when the clinical circumstances suggest self-harm.


Drug and Disease Interactions

Other medications or substances that depress the central nervous system can produce additive CNS and respiratory depression when combined with tramadol.

Examples include other sedative or opioid substances.


Pregnancy and Lactation

The historical FDA classification listed tramadol as Pregnancy Category C.

Animal studies demonstrated adverse fetal effects, while adequate controlled human studies were unavailable.

Tramadol is excreted into breast milk in small amounts, historically estimated at approximately 0.1% of the maternal dose.


Differential Diagnosis

Other toxic causes of CNS depression include:

Opioids, benzodiazepines, barbiturates, ethanol, baclofen, and gamma-hydroxybutyrate.

Non-toxicologic causes include:

Head trauma, CNS infection, hypoglycemia, hypoxia, and electrolyte or other metabolic disturbances.


Clinical Features

The main manifestations of overdose are related to CNS and respiratory depression.

Patients may also develop gastrointestinal, cardiovascular, neurologic, or musculoskeletal complications.


Vital Signs

Tachycardia and hypertension may occur, although these findings are uncommon.


HEENT

Miosis may occur after acute overdose.


Cardiovascular Effects

Large overdoses may cause:

Hypotension

and, rarely:

Myocardial ischemia


Pulmonary Effects

Respiratory depression is an important manifestation of tramadol overdose.

Rarely, pulmonary edema may develop.


Gastrointestinal Effects

Nausea and vomiting are common.


Renal and Genitourinary Effects

Urinary retention may occur during overdose.


Musculoskeletal Effects

Hypertonia may develop.

Rhabdomyolysis can occur, particularly in severe poisoning.


Neurologic Effects

CNS depression is common after significant overdose.

Patients may become:

Drowsy, confused, obtunded, or unconscious.

Seizures may also occur, although the original description characterizes them as relatively uncommon.


Laboratory Evaluation

Minimally symptomatic patients may not require extensive laboratory testing.

In patients with altered mental status, useful studies include:

Serum electrolytes

Glucose

BUN and creatinine

Creatine kinase

and monitoring of oxygenation.


Pulse Oximetry

Pulse oximetry should be used in patients with significant CNS or respiratory depression.


ECG

An ECG may be obtained in significant overdose, particularly when the ingestion history is uncertain or cardiovascular abnormalities are present.


Screening for Coingestants

In deliberate or uncertain overdose, acetaminophen and salicylate concentrations may be obtained to identify an occult coingestion.


Additional Neurologic Evaluation

When CNS depression cannot be fully explained by tramadol exposure, further investigation may include:

Head CT

Lumbar puncture

Toxicology testing

or other studies directed by the clinical presentation.


Treatment

The general management of tramadol toxicity resembles that of other opioid poisonings.

The priorities are:

Airway protection + respiratory support + circulation support

The amount taken, timing of ingestion, and possible coingestants should be determined whenever possible.


When to Seek Toxicology Assistance

Poison-center or toxicology consultation is appropriate when:

Severe or persistent toxicity develops

or when:

A coingestant, drug interaction, or underlying medical condition complicates management.


Referral to a Health-Care Facility

Medical evaluation is appropriate when:

Symptoms develop

Intentional overdose is suspected

The history is unreliable

or

Important coingestants or medical conditions are present.


Admission

Hospital admission is appropriate for patients with:

CNS depression

Hypotension

or

Respiratory depression


Decontamination – Out of Hospital

Vomiting should not be induced.


Decontamination – In Hospital

The historical management approach included gastric lavage after a large recent ingestion or severe poisoning.

A single dose of activated charcoal was also recommended after a substantial recent ingestion.

Airway protection is particularly important because tramadol can cause CNS depression and seizures.


Antidote

Naloxone is the opioid antagonist used for tramadol-associated opioid toxicity.

The historical regimen described:

Naloxone 2 mg IV initially

If there was no response:

Increase to 4 mg IV

If there was still no response after further escalation, additional naloxone was considered unlikely to provide benefit.


Supportive Care

Even when naloxone is given, supportive care remains essential.

Patients with inadequate ventilation may require:

Supplemental oxygen

Bag-mask ventilation

or

Endotracheal intubation with mechanical ventilation

depending on severity.


Seizures

If seizures occur, they require prompt treatment while airway and respiratory status are monitored closely.


Patient Monitoring

Symptomatic patients should have continuous monitoring of:

Respiratory function

and

Cardiac function


Respiratory Monitoring

Patients with respiratory depression may require:

Arterial blood-gas assessment

and

Pulse oximetry

to evaluate oxygenation and ventilation.


Observation

The original guidance recommends approximately 6 hours of observation after treatment to monitor for recurrent or delayed symptoms.


Expected Course and Prognosis

With adequate supportive care, most patients recover from tramadol overdose without significant long-term complications.

The major immediate threats are:

Respiratory depression

CNS depression

Hypotension

and, in some patients:

Seizures


Discharge From the Emergency Department

An asymptomatic patient may be considered for discharge after an adequate period of observation, historically approximately 6 hours, provided that:

No toxic effects develop

and

Appropriate psychiatric assessment has been completed when indicated.


Discharge From Hospital

Hospitalized patients may be discharged when:

Clinical toxicity has resolved

and they have remained stable without requiring naloxone for an adequate period.

The original text suggests approximately 6 hours without further naloxone requirement.


Important Pitfalls

Do not assume that all CNS depression in a patient who has taken tramadol is caused by tramadol alone.

Other serious causes should be considered, including:

Coingested sedatives or opioids

Head trauma

Infection

Hypoglycemia

Hypoxia

and other metabolic disturbances.


High-Yield Toxicology Pearls

Tramadol is a synthetic analgesic with both opioid and monoaminergic activity.


Its main toxic effects include:

CNS depression + respiratory depression + nausea/vomiting + hypotension ± seizures


Tramadol also inhibits:

Serotonin reuptake

and

Norepinephrine reuptake.


Miosis may occur after acute overdose.


Significant respiratory depression requires:

Airway support + oxygenation/ventilation


Naloxone can reverse the opioid component of tramadol toxicity.


There is no reliably defined toxic dose, although ingestion of several grams has been associated with fatal poisoning in adults.


In significant overdose, monitor:

Mental status

Respiratory function

Cardiac function

and appropriate laboratory studies.


The most important diagnostic warning is:

Do not attribute unexplained CNS depression solely to tramadol until other toxicologic, neurologic, and metabolic causes have been considered.



Image description
0 Comments